Tengion, a company involved in regenerative medicine, announced the addition of two renal research and clinical experts, Ben Humphreys, M.D., Ph.D., from the Harvard Stem Cell Institute and Giuseppe Remuzzi, M.D., F.R.C.P., from the Mario Negri Institute, to its panel of R&D advisors.

Remuzzi is the head of nephrology and dialysis and chairman of the department of transplantation at Bergamo Hospital and head of the Negri Bergamo Laboratories. He leads a team of researchers studying human renal diseases and their corresponding experimental models from the perspective of pathophysiology and therapeutic intervention.

Humphreys is an assistant professor of medicine at Harvard Medical School and principal faculty member of the Harvard Stem Cell Institute, where he is also co-director of the Institute’s Kidney Program. He is the recipient of a Harvard Stem Cell Institute Seed Grant, the National Kidney Foundation Young Investigator Award and the American Society of Nephrology Gottschalk Research Scholar Award. He investigates kidney repair for translation into therapies for kidney disease.